Study: Low-Carb Matches Low-Fat Plus Orlistat (Alli) Treatment For Weight Loss And Health Improvements

Filed under: Health,Study — @ January 26, 2010

Duke University School of Medicine researcher Dr. William Yancy

Brand new weight loss methods are introduced to the general public each and every year and people are left to their own devices wondering how to decipher the differences between the good and the bad. With slick marketing claims like “scientifically-proven” and even “FDA-approved,” Joe and Jane Consumer out there doesn’t know who or what to believe. One of the most heavily-promoted diet concepts to hit the American market in recent years is the weight loss medication called orlistat, commonly known as and sold commercially as Alli.

What if we could prove from the scientific community that weight loss drugs like Alli (orlistat) along with a “sensible” low-fat diet outperformed other diets like a high-fat, low-carb one, for example? Well, now we do thanks to Duke University researcher Dr. William Yancy who released a new 48-week clinical study published in the January 25, 2010 issue of Archives of Internal Medicine. He wanted to compare the effects of a low-carb, ketogenic diet (LCKD) with a orlistat therapy combined with a low-fat diet (O + LFD) to measure their impact on weight loss, blood pressure, cholesterol, blood sugar, insulin, and HgA1c levels.

Click here to read the astonishing results of the first-ever study to examine and compare the weight and health benefits of the most highly-touted diet drug combined with a low-fat diet with a high-fat, low-carb diet.


CarbWire is an online magazine of everything low-carb. Whether you're already on a diet, or are just doing research, we provide the most up-to-date info on the web.


By topic

CarbWire RSS Feed Add to MyYahoo

Content Copyright © 2004-2022